Endeavor8 is a venture capital firm founded in 2021 and based in San Francisco, California. It invests in early-stage entrepreneurs and scientists who apply novel technologies originally developed in high-margin industries to the food, agriculture, energy, and climate sectors.
The firm targets companies addressing evolving consumer preferences in food, the discovery of new chemical and biological compounds, data-driven improvements in operations, and innovative solutions for finance and risk management. Its approach draws on expertise in biotechnology, artificial intelligence, and machine learning to create impact across the entire food value chain.
Endeavor8 maintains a portfolio of companies spanning AI-powered crop protection discovery platforms, climate prediction software, location intelligence tools for retail and foot traffic analysis, A/B testing platforms for physical stores, producers of mobile biochar and carbon credits, financial solutions and marketplaces for farmers and produce, novel protein production such as sunflower-based ingredients, trade finance lending platforms, biological crop protection technologies, gene-editing biopesticides, materials and chemical development platforms, and veterinary biotechnology applications.
The firm operates primarily from the United States with investments focused on U.S.-based startups but with technologies that have global applicability. It is an independent venture capital entity led by General Partner and CEO Karl Kerksiek, formerly of Finistere Ventures, along with a team of venture partners and associates with backgrounds in technology, finance, and life sciences. In the agtech and climate investment landscape, Endeavor8 participates in financing rounds for innovative companies, including the Series A for Robigo, which develops engineered microbial products for crop protection.
Funding will accelerate US launch of one‑time engineered microbes that claim season‑long control of fungal diseases; ARGO™ platform promises sub‑20‑month development.
